COGT CIK: 1622229

Cogent Biosciences, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−58.8
FY22:
−119
FY23:
−154
FY24:
−208
FY25:
−264
Change from FY21 to FY25
millions USD
FY21:
−1.72
FY22:
−125
FY23:
−97.8
FY24:
38.3
FY25:
−400
Change from FY21 to FY25
millions USD
FY21:
38.0
FY22:
164
FY23:
164
FY24:
214
FY25:
878
millions USD
FY21:
−22.5
FY22:
−79.8
FY23:
−87.9
FY24:
44.9
FY25:
214
(positive)
Change from FY21 to FY25
millions USD
FY21:
−60.5
FY22:
−126
FY23:
−156
FY24:
−208
FY25:
−266

All amounts in millions USD Data source:SEC EDGAR